Publications by authors named "Jonathan Robertson"

Claim this Profile
W
What is the prevalence of anabolic-androgenic steroid use among women? A systematic review.
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, April Henning, Eric H Y Lau

Addiction· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the use of performance and image enhancing drugs (PIEDs) in women an issue of concern? The findings from a stakeholder consultation.
Matthew Dunn, Timothy M Piatkowski, Jonathan Robertson, Severine Lamon

J Sci Med Sport· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α4-Containing GABA Receptors on DRD2 Neurons of the Nucleus Accumbens Mediate Instrumental Responding for Conditioned Reinforcers and Its Potentiation by Cocaine.
Tom Macpherson, Claire I Dixon, Jonathan Robertson, Marsha M Sindarto, Patricia H Janak

eNeuro· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.
Tim Piatkowski, Jonathan Robertson, Severine Lamon, Matthew Dunn

Harm Reduct J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.
Aili L Lazaar, Lucy Yang, Rebecca L Boardley, Navin S Goyal, Jonathan Robertson

Br J Clin Pharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis--two randomised controlled trials.
Sabine Dölle, Nadine Hielscher, Philippe Jean Bareille, Kelly Hardes, Jonathan Robertson

Skin Pharmacol Physiol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.
Emiliangelo Ratti, David J Carpenter, Stefano Zamuner, Sofia Fernandes, Lisa Squassante, Jonathan Robertson

Sleep· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study.
Anthony Cahn, Simon Hodgson, Robert Wilson, Jonathan Robertson, Joanna Watson

BMC Pharmacol Toxicol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety, and Tolerability Following the Administration of a Single Dose of a Combination Tablet Containing Sumatriptan and Naproxen Sodium in Adolescent Patients With Migraine and in Healthy Adult Volunteers.
Alienor Berges, Jonathan Robertson, James Upward, Scott Meyers, Chao Chen

Clin Pharmacol Drug Dev· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury.
Praveen Anand, Ravikiran Shenoy, Joanne E Palmer, Amanda J Baines, Robert Y K Lai, Jonathan Robertson

Eur J Pain· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis